Sense Biodetection

Provider of point of care molecular diagnostics solutions

placeAbingdon, England, United Kingdom calendar_todayFounded 2014 groups43 employees language sense-bio.com

Registered entities

Investor mix

29 investors on record; lead investors include Mercia, Koch Disruptive Technologies, Cambridge Innovation Capital, Earlybird.

Investor typeCountShare
Venture capital517%
Other / undisclosed2483%
Coming soon